Results 31 to 40 of about 31,965 (231)

The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes [PDF]

open access: yes, 2013
The monomer of influenza haemagglutinin is synthesized as a single polypeptide precursor that during maturation is cleaved by proteases into two active subunits. Other studies have demonstrated that the human Transmembrane Protease Serine 2 (TMPRSS2) can
Ferrara, Francesca   +7 more
core   +1 more source

TMPRSS2 overexpression attenuates NCOA7-mediated restriction. [PDF]

open access: yes, 2021
(A) A549-ACE2 cells with or without TMPRSS2 were infected with increasing volumes of SARS-CoV-2 Spike pseudotyped vector expressing luciferase (SARS-2). Luciferase activity was measured 48 h post-infection.
David A. Matthews (542987)   +11 more
core   +1 more source

Publication trend of TMPRSS2 as SARS-CoV-2 receptor during the COVID-19 pandemic [PDF]

open access: yesPharmaciana, 2023
The Coronavirus Disease 2019 (COVID-19) pandemic has not yet been fully under public health control, which is still currently impacting a large number of people worldwide in 2023.
Lalu Muhammad Irham   +5 more
doaj   +1 more source

TMPRSS2-ERG fusion isoforms. [PDF]

open access: yes, 2016
(A) Genomic structure of the TMPRSS2–ERG fusion transcripts discovered from deep sequencing data by InFusion. Isoform 3 is a known transcript, while isoforms 1 and 2 are novel. Transcript names are taken from the Ensembl v.68 database.
Alexander Seitz (3372767)   +5 more
core   +1 more source

DataSheet1_Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors.zip [PDF]

open access: yes, 2021
Although SARS-CoV-2 entry to cells strictly depends on angiotensin-converting enzyme 2 (ACE2), the virus also needs transmembrane serine protease 2 (TMPRSS2) for its spike protein priming.
Maryam Farrokhnia (1668937)   +3 more
core   +1 more source

Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections

open access: yesFrontiers in Molecular Biosciences, 2020
Background: The current COVID-19 pandemic has affected most severely people with old age, or with comorbidities like hypertension, diabetes mellitus, and cancer.
Satyendra C. Tripathi   +6 more
doaj   +1 more source

Spontaneous Binding of Potential COVID-19 Drugs to Human Serine Protease TMPRSS2 [PDF]

open access: yes, 2020
Effective treatment or vaccine is not yet available for combating SARS coronavirus 2 (SARSCoV-2) that caused the COVID-19 pandemic. Recent studies showed that two drugs, Camostat and Nafamostat, might be repurposed to treat COVID-19 by inhibiting human ...
Haixia, Zhu   +5 more
core   +1 more source

Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors

open access: yesFrontiers in Chemistry, 2021
Although SARS-CoV-2 entry to cells strictly depends on angiotensin-converting enzyme 2 (ACE2), the virus also needs transmembrane serine protease 2 (TMPRSS2) for its spike protein priming.
Mehdi Mahmudpour   +4 more
doaj   +1 more source

Impact of ACE2 and TMPRSS2 Expression in Patients With Preeclampsia

open access: yesIn Vivo, 2023
As maternal morbidity and mortality during pregnancy have increased during the COVID-19 pandemic, studies on pregnancy-related complications from SARS-CoV-2 infection are being actively conducted. Considering that pregnant women with COVID-19 may develop a preeclampsia (PE)-like syndrome, it is necessary to differentiate it from PE because true PE can ...
Ji Eun, Park   +7 more
openaire   +2 more sources

Detection of tmprss2-erg and tmprss2-egr1 gene fusion in prostate cancer from a Chinese population [PDF]

open access: yesEgyptian Journal of Medical Human Genetics, 2020
Abstract Background TMPRSS2: ETS gene fusion occurs recurrently in a high proportion of prostate cancer (PCa) patients in Western countries. However, for Chinese PCa patients, no solid conclusion could be drawn from the present studies, as the results varied considerably between the limited reports.
Changqing Xu   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy